United States Data Bridge Market Research conducted an extensive qualitative study focusing on the “Gene Synthesis Software Market“. “Our commitment to delivering the most fitting, exceptional, ...

Support for Xilinx's low-cost, high-volume Spartan-3A family of I/O-optimized FPGAs is now offered by Synplicity's Synplify Pro FPGA synthesis software. The Synplify Pro FPGA synthesis tool helps ...

HeartBeam (NASDAQ: BEAT) has been initiated with a Buy rating and $4 price target by Roth Capital Partners, which highlighted the company’s near-term catalyst of expected FDA clearance for its ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it ...

Russell Klein, program director for Siemens EDA’s High-Level Synthesis Division, talks with Semiconductor Engineering about ...

HeartBeam has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram (ECG) synthesis software tailored to assess various cardiac rhythms and ...

The Peptide-ExplorerLT ™ is designed for scientists who need to optimize and explore linear peptide synthesis. The product is a high-spec flow chemistry system that uses continuous flow. The product ...

Company engaging in multiple options for a constructive resolution Strategy is underpinned by a clinical study that achieved the agreed upon endpoints Company believes that labeling modifications can ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc., (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced ...